CMIF-P TREATMENT IN PATIENTS WITH POOR-PROGNOSIS ADVANCED BREAST-CANCER

被引：0
|
作者：
KUHRER, I [1 ]
LUDWIG, H [1 ]
SCHEITHAUER, W [1 ]
ZIELINSKI, C [1 ]
机构：
[1] VIENNA UNIV,MED KLIN 2,A-1090 VIENNA,AUSTRIA
来源：
BLUT | 1987年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF ADVANCED POOR-PROGNOSIS BREAST-CANCER IN YOUNG-WOMEN WITH DOXORUBICIN PLUS IFOSFAMIDE MESNA
    MILLWARD, MJ
    CANTWELL, BMJ
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 177 - 177
  • [2] TENASCIN IN BREAST-CANCER DEVELOPMENT - IS EPITHELIAL TENASCIN A MARKER FOR POOR-PROGNOSIS
    YOSHIDA, T
    ISHIHARA, A
    HIROKAWA, Y
    KUSAKABE, M
    SAKAKURA, T
    CANCER LETTERS, 1995, 90 (01) : 65 - 73
  • [3] ALLELIC LOSS ON DISTAL CHROMOSOME-17P IS ASSOCIATED WITH POOR-PROGNOSIS IN A GROUP OF BRAZILIAN BREAST-CANCER PATIENTS
    NAGAI, MA
    PACHECO, MM
    BRENTANI, MM
    MARQUES, LA
    BRENTANI, RR
    PONDER, BAJ
    MULLIGAN, LM
    BRITISH JOURNAL OF CANCER, 1994, 69 (04) : 754 - 758
  • [4] WEEKLY LOW-DOSE ADRIAMYCIN IN POOR PROGNOSIS PATIENTS WITH ADVANCED BREAST-CANCER
    NAMER, M
    KHATER, R
    HERY, M
    FRENAY, M
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) : 92 - 92
  • [5] FLOW CYTOMETRIC DNA-PLOIDY DEFINES PATIENTS WITH POOR-PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER
    BALSLEV, I
    CHRISTENSEN, IJ
    RASMUSSEN, BB
    LARSEN, JK
    LYKKESFELDT, AE
    THORPE, SM
    ROSE, C
    BRIAND, P
    MOURIDSEN, HT
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (01) : 16 - 25
  • [6] Innovative CPMV immunotherapy: A canine model for poor-prognosis breast cancer treatment
    Valdivia, Guillermo
    Perez-Alenza, Dolores
    Barreno, Lucia
    Alonso-Diez, Angela
    de Oliveira, Jessica Fernanda Affonso
    Suarez-Redondo, Maria
    Fiering, Steven F.
    Steinmetz, Nicole F.
    Pena, Laura
    CANCER RESEARCH, 2024, 84 (06)
  • [7] HYPERPROLACTINEMIA IS AN INDICATOR OF PROGRESSIVE DISEASE AND POOR PROGNOSIS IN ADVANCED BREAST-CANCER
    HOLTKAMP, W
    NAGEL, GA
    WANDER, HE
    RAUSCHECKER, HF
    VONHEYDEN, D
    INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (03) : 323 - 328
  • [8] PATHOLOGY OF THE UTERUS AND THE PROGNOSIS OF PATIENTS WITH ADVANCED BREAST-CANCER
    LANGENS, R
    KOENDERS, PG
    BENRAAD, TJ
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 166 - 166
  • [9] YNZ22 ALLELE LOSS FROM 17P IS ASSOCIATED WITH POOR-PROGNOSIS AT 5 YEARS IN BREAST-CANCER
    THOMPSON, AM
    STEEL, CM
    CHETTY, U
    CARTER, DC
    BRITISH JOURNAL OF SURGERY, 1995, 82 (11) : 1571 - 1571
  • [10] PRESENT STATUS AND POTENTIAL ROLE OF HIGH-DOSE ADJUVANT CHEMOTHERAPY IN BREAST-CANCER WITH POOR-PROGNOSIS
    THURLIMANN, B
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1994, 255 : S379 - S380
12345